SCHEDULE 13G/A: Capital Research Global Investors Discloses 4.8% Stake in Silvaco Group, Inc.

Capital Research Global Investors has filed an amended Schedule 13G, reporting a 4.8% beneficial ownership stake in Silvaco Group, Inc. as of March 31, 2025.

Summary

• Capital Research Global Investors (CRGI) reported beneficial ownership of 1,372,346 shares of Silvaco Group, Inc. common stock.
• This ownership represents 4.8% of the 28,672,399 shares of Silvaco Group, Inc. common stock believed to be outstanding.
• The filing is an Amendment No. 1 to a Schedule 13G, indicating an update to a previously reported position.
• CRGI is identified as a division of Capital Research and Management Company (CRMC) and its investment management subsidiaries and affiliates.
• The shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Silvaco Group, Inc.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. While a 13G is a routine disclosure, the presence of a large, reputable institutional investor holding a significant, albeit passive, stake can be viewed as a positive signal of confidence in the company.

Positives

• The disclosure of a significant stake by a reputable institutional investor like Capital Research Global Investors may signal confidence in Silvaco Group, Inc.'s long-term prospects.
• The filing confirms that the investment is passive, held in the ordinary course of business, and not intended to influence control, which can provide stability regarding corporate governance.

Negatives

• The beneficial ownership percentage of 4.8% is below the 5% threshold, meaning Capital Research Global Investors is a passive investor and not seeking to influence control, which limits their direct impact on strategic decisions.

Risks

• The filing explicitly states that the shares were not acquired or held for the purpose of changing or influencing control of Silvaco Group, Inc., mitigating potential governance risks from this specific shareholder.

Future Outlook

This Schedule 13G filing does not contain any forward-looking statements or guidance regarding Silvaco Group, Inc.'s future performance or Capital Research Global Investors' future investment intentions beyond the certification of passive holding.

Management Comments

• "The securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §§ 240.14a-11." (Certification by Jae Won Chung, Vice President and Senior Counsel II, Capital Research and Management Company)

Industry Context

This filing reflects ongoing institutional investment activity in publicly traded companies, where large asset managers like Capital Research Global Investors take passive stakes in companies like Silvaco Group, Inc. It indicates continued institutional interest in the technology or semiconductor sector, depending on Silvaco's primary business.

Stakeholder Impact

• Shareholders: Provides transparency regarding a significant institutional holder's stake, which can influence market perception and liquidity. It may also be seen as a vote of confidence from a major investor.

Next Steps

• Capital Research Global Investors will file further amendments to Schedule 13G if their beneficial ownership percentage changes significantly (e.g., crosses 5% or drops below 0%) or if their investment intent changes from passive to active.

Key Dates

Keywords

Silvaco Group Inc., Capital Research Global Investors, Schedule 13G, Beneficial Ownership, Common Stock, Institutional Investor, SEC Filing, Investment Management